Dr. Iyanuoluwa Odole is a dedicated healthcare professional passionate about achieving health equity, particularly in cancer care and genetics. As an experienced healthcare consultant, she specializes in developing and implementing strategies that improve patient outcomes, with a focus on advancing cancer care. Her journey in the field of medicine began at the University of Ibadan, Nigeria, where she earned a degree in Dentistry and Dental Surgery.
Fueled by her commitment to public health, Dr. Odole pursued a Master of Public Health (MPH) in Epidemiology and Global Health at Yale University, where she was a distinguished Horstmann Scholar, PEO International Peace Scholar, and Roothbert Fellow. At Yale, she became the inaugural Global Health Academic Leadership Fellow at the Yale School of Public Health, playing a pivotal role in shaping the Global Health concentration. Her leadership extended beyond academics, as she also served as a Diversity, Equity, Inclusion, and Belonging (DEIB) Ambassador, spearheading initiatives to promote diversity and inclusion.
Throughout her career, Dr. Odole has been a vocal advocate for equitable healthcare, particularly in the oncology space. Her innovative work focuses on identifying cancer risk factors, understanding genetic predispositions, and enhancing early detection and personalized treatment, especially for underserved racial and ethnic communities. She has also leveraged technology to make healthcare more accessible for adults with low health literacy, developing patient-centered digital health tools that have significantly increased lung cancer screening uptake and empowered older women to make informed decisions about breast cancer screening.
Dr. Odole’s contributions to the field have been widely recognized, including receiving the prestigious Margaret McNamara Award for her impactful work. As a transformative figure in oncology, she continues to play a crucial role in redefining how cancer is understood, prevented, and treated, with a steadfast commitment to advancing health equity for those most in need.
Tell us a little bit about your background.
Sure! I started my medical journey in Nigeria, where I trained as a dental surgeon. Early on, I developed an interest in treating patients diagnosed with head and neck cancers, and experienced firsthand the challenges of late-stage presentations and poor prognoses. These experiences shaped my understanding of the significant challenges in cancer care, particularly in resource-limited settings.
After graduating, I took a non-traditional path away from clinical practice, joining a biotechnology company addressing the underrepresentation of African populations in global genomics research. During this time, I learned how only 2% of the data used in genome-wide association studies come from people of African ancestry, despite Africa being the most genetically diverse continent. This discovery opened my eyes to the broader systemic gaps in global health research and fueled my desire to gain expertise in public health practice. I pursued a Master of Public Health in Epidemiology and Global Health at Yale University, focusing on oncology and genetics. My goal was to acquire the skills necessary to improve patient outcomes for underserved groups, including racial and ethnic minorities, women, older adults, individuals with low health literacy, and those from low socioeconomic backgrounds.
My career has since been centered around oncology, combining my clinical background with research expertise and public health practice. I am dedicated to driving change, particularly for those who are often overlooked in cancer research and care. My work focuses on leveraging data-driven strategies to improve cancer care, using evidence-based approaches to enhance early detection, personalize treatment, and address disparities.
What inspired your transition from dentistry to public health, particularly focusing on cancer care and health equity?
My journey from dentistry to public health wasn’t really a transition; it was more of an expansion of my focus. Working in dentistry allowed me to engage closely with patients, providing one-on-one care, which was rewarding. However, over time, it became clear that many of the challenges my patients faced were not limited to clinic visits. It was no longer about just fixing a dental issue, but more about recognizing the broader context of their health. Particularly, many of them presented with advanced cancer stages and other serious conditions that could have been prevented or better managed if systemic issues—like healthcare access, early detection, and socioeconomic barriers—were addressed.
So, it wasn’t much about leaving clinical work behind, as much as it was about broadening my impact. I wanted to address the systemic challenges affecting patient care, especially for those in underserved communities. This drive to look beyond individual patient care and focus on the bigger picture is what led me to public health, allowing me to work on improving cancer care and advancing health equity on a larger scale.
Recently, I did some work on identifying racial and genetic variations in early-onset breast cancer emphasizing the need for health equity. This work showed the importance of developing targeted prevention strategies, including genetic counseling and testing, particularly for racial groups disproportionately impacted by early-onset breast cancer.
You were the inaugural Global Health Academic Leadership Fellow at the Yale School of Public Health, what was the accomplishment like and how did it shape your perspective on global health?
One of the most rewarding aspects of being the Global Health Academic Leadership Fellow was working closely with students and faculty to develop initiatives that not only broadened academic opportunities but also fostered a deep sense of community and collaboration in the field. I organized events that brought together diverse voices, sparking conversations about pressing global health challenges and inspiring innovative solutions. Witnessing students engage with global health issues, often sharing their own experiences and aspirations, reinforced my belief in the change public health can bring.
You’ve also developed patient-centered digital health tools to increase cancer screening uptake. Could you explain how technology can play a role in improving healthcare accessibility for people with low health literacy?
For many patients, navigating the healthcare system can feel overwhelming. Complex medical words, intricate processes, and a lack of clear information can create barriers that prevent people from seeking the care they need. This challenge is particularly pronounced in underserved communities, where factors like education and socioeconomic status can limit health literacy. That’s where my work comes in, focused on creating digital tools that simplify information and make it easy to understand. For example, I designed and tested a tool that breaks down the information about lung cancer screening into straightforward, easy-to-understand language, using visuals to illustrate key points. Lung cancer is a leading cause of cancer deaths globally, and early detection through screening can significantly improve survival rates. By presenting information in an accessible way, we empower patients to recognize the importance of screening and to make informed decisions about their health.
During your time as a DEIB Ambassador at Yale, you spearheaded initiatives to promote diversity and inclusion. How do you think diversity and inclusion practices contribute to achieving health equity?
Health equity can only be achieved when the healthcare workforce, research, and policies reflect the diversity of the communities they serve. Embracing diversity means recognizing and addressing the unique health challenges faced by different populations—either due to race, ethnicity, gender, socioeconomic status, or cultural differences. Inclusion, on the other hand, ensures that these diverse voices are not only present but are actively contributing to shaping solutions. This is vital in global health, where one-size-fits-all approaches often fall short.
My time as a DEIB Ambassador focused on ensuring everyone had a seat at the table, while also making sure that every voice is heard and valued. By integrating diversity and inclusion into the fabric of our healthcare systems, we can move closer to a world where everyone, regardless of their background, has access to the care and support they need.
What advice would you offer young healthcare professionals who aspire to lead transformational change in the field of public health?
Don’t shy away from complex problems or uncomfortable conversations, especially those around inequity and access. The most significant changes often come from tackling the toughest issues. Be bold in your advocacy and willing to challenge the status quo, but also remain empathetic and grounded in the realities of the people you aim to help.
What future projects or initiatives are you most excited about in your continued efforts to transform how cancer is understood, prevented, and treated?
Looking ahead, I am excited about projects that push the boundaries of how we understand, prevent, and treat cancer. One area I am particularly interested in is leveraging data-driven strategies and technology to enhance early detection and personalized treatment. The integration of AI and machine learning in oncology, for instance, opens up possibilities for more accurate risk assessments and tailored interventions, which can be game-changers in cancer care. Cancer care is evolving rapidly, but without patient-centered approaches and community engagement, we risk widening the gaps in care. I believe that the future of oncology lies in truly understanding and integrating the patient’s voice and experience into every aspect of care, from prevention to survivorship.
